To Our ASRI Members, 

As many of you are aware, recent changes in leadership within the United States government have led to significant cuts—and proposed cuts—to federal funding for biomedical research and the provision of care for vulnerable populations. The members of the American Society for Reproductive Immunology (ASRI) rely on federal support to advance reproductive health. ASRI members are dedicated to addressing critical health challenges, including infertility, recurrent pregnancy loss, preterm birth, endometriosis, and cancers of the reproductive system. 

Unanticipated, unbudgeted, and severe reductions in federal support jeopardize the progress we have made and risk reversing critical advancements in reproductive health research. These cuts threaten to stall lifesaving discoveries and hinder the development of innovative treatments for millions of Americans. 

We strongly urge the administration to reconsider these actions and remain committed to investing in discovery and innovation in reproductive health. The individuals and families we serve desperately need the breakthroughs ASRI members are working toward—breakthroughs that have the potential to transform lives. 

For those who wish to contact state and federal representatives to emphasize the importance of sustaining investments in reproductive health research, their contact information can be found here. Additionally, this website provides data on the positive impact of NIH-funded research in each state, which may be useful when communicating with policymakers. 

Thank you for your commitment to advancing reproductive immunology and for your advocacy in support of research that improves health outcomes for all. 

David M. Aronoff, MD, FIDSA, FAAM, FRCP

President, American Society for Reproductive Immunology (ASRI)